Quercetin represses apolipoprotein B expression by inhibiting the transcriptional activity of C/EBPβ

PLoS One. 2015 Apr 15;10(4):e0121784. doi: 10.1371/journal.pone.0121784. eCollection 2015.

Abstract

Quercetin is one of the most abundant polyphenolic flavonoids found in fruits and vegetables and has anti-oxidative and anti-obesity effects. Because the small intestine is a major absorptive organ of dietary nutrients, it is likely that highly concentrated food constituents, including polyphenols, are present in the small intestinal epithelial cells, suggesting that food factors may have a profound effect in this tissue. To identify novel targets of quercetin in the intestinal enterocytes, mRNA profiling using human intestinal epithelial Caco-2 cells was performed. We found that mRNA levels of some apolipoproteins, particularly apolipoprotein B (apoB), are downregulated in the presence of quercetin. On the exposure of Caco-2 cells to quercetin, both mRNA and protein levels of apoB were decreased. Promoter analysis of the human apoB revealed that quercetin response element is localized at the 5'-proximal promoter region, which contains a conserved CCAAT enhancer-binding protein (C/EBP)-response element. We found that quercetin reduces the promoter activity of apoB, driven by the enforced expression of C/EBPβ. Quercetin had no effect on either mRNA or protein levels of C/EBPβ. In contrast, we found that quercetin inhibits the transcriptional activity of C/EBPβ but not its recruitment to the apoB promoter. On the exposure of Caco-2 cells to quercetin 3-O-glucuronide, which is in a cell-impermeable form, no notable change in apoB mRNA was observed, suggesting an intracellular action of quercetin. In vitro interaction experiments using quercetin-conjugated beads revealed that quercetin binds to C/EBPβ. Our results describe a novel regulatory mechanism of transcription of apolipoprotein genes by quercetin in the intestinal enterocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apolipoproteins B / biosynthesis*
  • Apolipoproteins B / genetics
  • CCAAT-Enhancer-Binding Protein-beta / biosynthesis*
  • CCAAT-Enhancer-Binding Protein-beta / genetics
  • Caco-2 Cells
  • Gene Expression Regulation / drug effects
  • Humans
  • Promoter Regions, Genetic
  • Quercetin / pharmacology*
  • RNA, Messenger / biosynthesis
  • Transcriptional Activation / drug effects

Substances

  • Apolipoproteins B
  • CCAAT-Enhancer-Binding Protein-beta
  • RNA, Messenger
  • Quercetin

Grants and funding

This study was supported by grants for project research from the Ministry of Agriculture, Forestry and Fisheries (Development of Fundamental Technology for analysis and evaluation of functional agricultural products and functional foods), Nestle Research Foundation, and research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Japanese Council for Science, Technology and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.